Table 1 Clinical and demographical data
From: Abundant kif21b is associated with accelerated progression in neurodegenerative diseases
| Â | NDC (n = 58) | MS (n = 50) | AD (n = 50) | p-value |
|---|---|---|---|---|
Age at death (SD) | 71 (13) | 63 (13) | 66 (9) | 0.004 |
Median post-mortem delay in hours (IQR) | 7:35 (6:18-9:16) | 6:57 (5:25-8:15) | 5:20 (4:27-6:13) | 4*10-7 |
pH (IQR) | 6.64 (6.45-6.94) | 6.50 (6.36-6.71) | 6.47 (6.34-6.67) | 0.02 |
Percentage female | 72 | 74 | 76 | 0.92 |
Kif21b rs12122721 genotype n (%) | Â | Â | Â | Â |
GG | 27 (46.6) | 31 (62.0) | 21 (42.0%) | 0.24 |
AG | 26 (44.8%) | 15 (30.0) | 26 (52.0%) | |
AA | 3 (5.2%) | 4 (8.0%) | 3 (6.0%) | |
Undetermined | 2 (3.4%) | 0 (0) | 0 (0) |